Arima Genomics, Inc. has announced the publication of a significant research study that underscores the effectiveness of the Aventa™ Lymphoma test. This study, conducted in collaboration...
Avidity Biosciences (NASDAQ:RNA) is preparing to release its fourth-quarter earnings for the fiscal year 2025 on February 26, 2026, before the market opens. Analysts anticipate that...